Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 24 of 100

  • Pentagon DNA Test Kits WarningHealth

    Pentagon Latest to Warn About Concerns Around DNA Test Kits

    By
  • Sarepta Stock Roche DealHealth

    Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal

    By
  • Brainstorm Health 2020 SignoffNewsletters

    A Holiday Reflection and Temporary Farewell

    By
  • Healthcare Ideas 2020sNewsletters

    The Ideas That Will Shape Health Care in the Next Decade

    By
  • Big Pharma ROINewsletters

    Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low

    By
  • Multiple myeloma MMRFNewsletters

    GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug

    By
  • Drugs and Tech Revolutionizinf HealthcareHealth

    The 4 Most Game-Changing Medical Advances of the Past Decade

    By
  • Vaping E-Cig Lung Respiratory Illness StudyNewsletters

    A New Study Shows the Damage Just 3 Years of Vaping Could Do to Your Lungs

    By
  • Duchenne Sarepta FDANewsletters

    FDA Approves Sarepta Duchenne Drug in Stunning Reversal

    By
  • Stephen Hahn FDA Commissioner ConfirmedNewsletters

    Meet Stephen Hahn, the New FDA Commissioner

    By
  • Fertility Business MPW Next GenConferences

    The 3 Things That Have Been Holding Back the Fertility Business

    By
  • Home Depot Theft Opioid CrisisNewsletters

    Is Loneliness Driving the Opioid Epidemic?

    By
  • Flu Season 2020Newsletters

    Flu Season Came Early. Here’s What You Should Do

    By
  • CVS CEO Larry Merlo Aetna Deal InterviewNewsletters

    CVS CEO on What’s Happened After Its Aetna Merger—and What Comes Next

    By
  • Biogen Alzheimers Drug DataNewsletters

    The Broader Implications of Biogen’s Divisive Alzheimer’s Drug

    By